In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 4485-4487

  Biancalana, Fernanda Simas Corrêa ^a   Lyra, Luzia ^a   Schreiber, Angélica Zaninelli ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; DEMATIACEOUS; DRUG POTENTIATION; FRACTIONAL INHIBITORY CONCENTRATION INDEX; FUNGUS ISOLATION; IN VITRO STUDY; INHIBITION KINETICS; MINIMUM INHIBITORY CONCENTRATION; MOULD; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG INTERACTIONS; FUNGI; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; PYRIMIDINES; TRIAZOLES;

EID: 80051810297     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01015-10     Document Type: Article

References (24)

1. Andrade, T S, L G M Castro, R S Nunes, V M Gimenes, and A E Cury. 2004. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 47:216-221. (Pubitemid 38903453)
2. Argenta, J S, et al. 2008. In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil. Antimicrob. Agents Chemother. 52:767-769. (Pubitemid 351170862)
3. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, 2nd ed. CLSI document M38-A2. CLSI, Wayne, PA.
4. Cuenca-Estrella, M. 2004. Combinations of antifungal agents in therapy - what value are they? J. Antimicrob. Chemother. 54:854-869. (Pubitemid 39529979)
5. De Bedout, C., B L Gómez, and A. Restrepo. 1997. In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals. Rev. Inst. Med. Trop. Sao Paulo 39:145-148.
6. Espinel-Ingroff, A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39:954-958. (Pubitemid 32209706)
7. Fothergill, A W, M G Rinaldi, and D A Sutton. 2009. Antifungal susceptibility testing of Exophilala spp.: A head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. Med. Mycol. 47:41-43.
8. Gómez-López, A., M. Cuenca-Estrella, E. Mellado, and J L Rodrigues-Tudela. 2003. In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota. Diagn. Microbiol. Infect. Dis. 45:199-202. (Pubitemid 36349660)
9. Kantarcioglu, A S, and G S De Hoog. 2004. Infections of the central nervous system by melanized fungi: A review of the cases presented between 1999 and 2004. Mycoses 47:4-13. (Pubitemid 38375592)
10. Kirkpatrick, W R, et al. 2005. Combination therapy with terbinafine and amphotercin B in a rabbit model of experimental invasive aspergillosis. Antimicrob. Agents Chemother. 49:4751-4753. (Pubitemid 41552609)
11. Krishnan-Natesan, S., P H Chandrasekar, E K Manavathu, and S G Revankar. 2008. Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine. Diagn. Microbiol. Infect. Dis. 62:443-446.
12. Llop, C., J. Sala, M D Riba, and J. Guarro. 1999. Antimicrobial susceptibility testing of dematiaceous filamentous fungi: Effect of medium composition at different temperatures and times of reading. Mycopathologia. 148:25-31.
13. McGinnis, M R, and L. Pasarel. 1998. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J. Clin. Microbiol. 36:2353-2355. (Pubitemid 28324097)
14. Meletiadis, J., J F Meis, S. De Hoog, and P E Verweij. 2000. In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs. Mycoses 43:309-312.
15. Meletiadis, J., J W Mouton, J F Meis, and P E Verweij. 2003. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob. Agents Chemother. 47:106-117. (Pubitemid 36070350)
16. Ortoneda, M., J. Capilla, F J Pastor, I. Pujol, C. Yustes, C. Serena, and J. Guarro. 2004. In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob. Agents Chemother. 48:2727-2729. (Pubitemid 38823452)
17. Pang, K R, J J Wu, D B Huang, and S K Tyring. 2004. Subcutaneous fungal infections. Dermatol. Ther. 17:523-531. (Pubitemid 39657282)
18. Revankar, S G 2007. Dematiaceous fungi. Mycoses 50:91-101.
19. Ruíz-Cendoya, M., M M Rodriguez, M. Mariné, F J Pastor, and J. Guarro. 2008. In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi. Int. J. Antimicrob. Agents 32:418-420.
20. Ryder, N S, and L. Leitner. 2001. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med. Mycol. 39:91-95. (Pubitemid 32192922)
21. Sabatelli, F., et al. 2006. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob. Agents Chemother. 50:2009-2015. (Pubitemid 43807519)
22. Suh, M K 2005. Phaeohyphomycosis in Korea. Jpn. J. Med. Mycol. 46:67-70. (Pubitemid 40755892)
23. Yu, J., L. Ruoyu, M. Zhang, L. Liu, and Z. Wan. 2008. In vitro interactions of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China. Med. Mycol. 46:745-747.
24. Zhang, J., et al. 2009. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: A report of three cases in Guangdong, China. Mycoses 52:176-181.